Hosted on MSN
Nasal spray shows promise in lowering COVID-19 risk
A phase 2 trial in Germany found that the antihistamine nasal spray azelastine significantly reduced COVID-19 infections and shortened illness duration among vaccinated adults. Participants using the ...
There's a surprising link between the nasal spray azelastine and COVID risk, one study says. Here, what the scientists found ...
At the moment, an influenza vaccine called FluMist is the only licensed intranasal vaccine approved for use in humans. The ...
Scientists are realizing just how wrong we've been about how our noses are structured, and how the sense of smell really ...
Hay fever season is here, bringing with it the familiar symptoms many people dread: sneezing, itchy eyes, and a persistent ...
Since 2007, Jezebel has been the Internet's most treasured source for everything celebrities, sex, and politics...with teeth.
The Iowa MAHA bill is headed to the Governor’s desk and would bring changes to schools, health treatments, and food ...
The odor receptors in the nose are not distributed at random but organized in a precise spatial pattern, two new studies ...
During the pandemic, Firebrick Pharma's (ASX:FRE) anti-infective nasal spray Nasodine seemed a walk-up start for inclusion in ...
The 510(k) clearances were granted to a dozen in vitro diagnostic tests and reagents which used a variety of detection methods and approaches.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results